DESIGN AND CURRENT STATUS OF THE CATZ STUDY: A PHASE III, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY AND SAFETY OF ADJUNCTIVE ZONISAMIDE IN PEDIATRIC PATIENTS WITH PARTIAL-ONSET SEIZURES

被引:0
|
作者
Rosati, A. [1 ]
Pellacani, S. [1 ]
van Maanen, R. [2 ]
Segieth, J. [2 ]
Guerrini, R. [1 ]
机构
[1] Univ Florence, Childrens Hosp Anna Meyer, Florence, Italy
[2] Eisai Ltd, Hatfield, Herts, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:71 / 71
页数:1
相关论文
共 50 条
  • [31] Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures
    Elger, Christian
    Bialer, Meir
    Cramer, Joyce A.
    Maia, Joana
    Almeida, Luis
    Soares-da-Silva, Patricio
    EPILEPSIA, 2007, 48 (03) : 497 - 504
  • [32] Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures
    Sperling, Michael R.
    Klein, Pavel
    Tsai, Julia
    EPILEPSIA, 2017, 58 (04) : 558 - 564
  • [33] Efficacy and Safety of Adjunctive Brivaracetam (BRV) for Partial-Onset (Focal) Seizures (POS) in Patients with Type IC Seizures at Baseline: Pooled Results fro Three Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
    Diaz, Anyzeila
    Elmoufti, Sami
    Schieman, Jimmy
    Whitesides, John
    NEUROLOGY, 2016, 86
  • [34] Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial
    Halasz, Peter
    Kalviainen, Reetta
    Mazurkiewicz-Beldzinska, Maria
    Rosenow, Felix
    Doty, Pamela
    Hebert, David
    Sullivan, Timothy
    EPILEPSIA, 2009, 50 (03) : 443 - 453
  • [35] Interim Efficacy and Safety Analysis of Adjunctive Perampanel in the Adolescent Population From the Extension Phase of 3 Double-Blind, Placebo-Controlled, Phase 3 (Core) Studies in Patients with Refractory Partial-Onset Seizures
    Renfroe, B.
    Yang, H.
    Williams, B.
    Huang, S.
    Laurenza, A.
    ANNALS OF NEUROLOGY, 2013, 74 : S172 - S172
  • [36] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Karbalaee, Monire
    Jameie, Melika
    Amanollahi, Mobina
    TaghaviZanjani, Fateme
    Parsaei, Mohammadamin
    Basti, Fatemeh A.
    Mokhtari, Saba
    Moradi, Kamyar
    Akhondzadeh, Shahin
    SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
  • [37] POPULATION PHARMACOKINETICS OF PERAMPANEL, A SELECTIVE, NONCOMPETITIVE AMPA RECEPTOR ANTAGONIST, IN PATIENTS WITH REFRACTORY PARTIAL-ONSET SEIZURES PARTICIPATING IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY
    Hussein, Z.
    Critchley, D.
    Ferry, J.
    Laurenza, A.
    EPILEPSIA, 2011, 52 : 248 - 249
  • [38] A MULTICENTER DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON ZONISAMIDE ON MEDICALLY REFRACTORY PATIENTS WITH COMPLEX PARTIAL SEIZURES
    WILDER, BJ
    RAMSAY, RE
    BROWNE, T
    SACKELLARES, JC
    EPILEPSIA, 1985, 26 (05) : 545 - 545
  • [39] Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
    Biton, Victor
    Berkovic, Samuel F.
    Abou-Khalil, Bassel
    Sperling, Michael R.
    Johnson, Martin E.
    Lu, Sarah
    EPILEPSIA, 2014, 55 (01) : 57 - 66
  • [40] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412